Congratulations on your new role. What are the main agendas behind the recently announced dual leadership at E...Read more
Australia based CSL Limited's part, CSL Behring has announced that the first patient has been enrolled in...Read more
Netherlands based Viroclinics Biosciences, a leading virology contract research organization, has announced th...Read more
Firms racing to develop antibody treatment for COVID-19
The Coronavirus COVID-19 has raged the world and has infected 8,993,659 cases and killed 469,587 (as of June 23, 2020. Source World Health Organization (WHO)). Pharma firms, scientists and governments all over the world are racing to find a cure for the virus. The entire world is waiting for the vaccine; Moderna’s mRNA vaccine will begin phase III study in July. Amidst all this, some biopharma companies are pushing to develop antibody based treatments for the virus. Does that have any merit? Why are firms putting billions of dollars into it when vaccines are the ultimate solution? Let’s find out.